180 Life Sciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch ATNF and buy or sell other stocks, ETFs, and their options commission-free!About ATNF
ETHZilla Corp. operates as a clinical-stage biotechnology company, which engages in the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company was founded by Marc Feldmann, Lawrence J.
CEOMcAndrew A. Rudisill
CEOMcAndrew A. Rudisill
Employees3
Employees3
HeadquartersPalm Beach, Florida
HeadquartersPalm Beach, Florida
Founded2016
Founded2016
Employees3
Employees3
ATNF Key Statistics
Market cap10.34M
Market cap10.34M
Price-Earnings ratio-0.30
Price-Earnings ratio-0.30
Dividend yield—
Dividend yield—
Average volume882.64K
Average volume882.64K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$174.60
52 Week high$174.60
52 Week low$6.58
52 Week low$6.58
Stock Snapshot
As of today, 180 Life Sciences(ATNF) shares are valued at $17.12. The company's market cap stands at 10.34M, with a P/E ratio of -0.30.
On 2025-11-13, 180 Life Sciences(ATNF) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 882.64K.
Over the past 52 weeks, 180 Life Sciences(ATNF) stock has traded between a high of $174.60 and a low of $6.58.
Over the past 52 weeks, 180 Life Sciences(ATNF) stock has traded between a high of $174.60 and a low of $6.58.
People also own
Based on the portfolios of people who own ATNF. This list is generated using Robinhood data, and it’s not a recommendation.